<SEC-DOCUMENT>0001279569-18-002372.txt : 20181128
<SEC-HEADER>0001279569-18-002372.hdr.sgml : 20181128
<ACCEPTANCE-DATETIME>20181128095628
ACCESSION NUMBER:		0001279569-18-002372
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20181127
FILED AS OF DATE:		20181128
DATE AS OF CHANGE:		20181128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		181204376

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 3pt">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 12pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&nbsp;6-K </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>REPORT OF FOREIGN ISSUER </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO RULE 13a-16 OR 15d-16
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF
1934 </b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>For the month of November 2018
</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Commission File No.&nbsp;001-38496</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Canopy Growth Corporation</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>1 Hershey Drive<br>
Smith Falls, Ontario<br>
K7A 0A8</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files
or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font>
<font style="font-family: Times New Roman, Times, Serif">Form 40-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(1):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(7):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant by furnishing
the information contained in this Form&nbsp;is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b)&nbsp;under
the Securities Exchange Act of 1934.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font>
<font style="font-family: Times New Roman, Times, Serif">&nbsp;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 3pt; margin-bottom: 12pt"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 8%">&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 90%">&nbsp;</td></tr>
<tr>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exhibit</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td>
    <td>&nbsp;</td>
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Description</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr style="vertical-align: top">
    <td nowrap style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">99.1</A></FONT></td>
    <td><FONT STYLE="color: Black">&nbsp;</FONT></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">Press
    Release - Battelle and Canopy Growth Announce Strategic Collaboration to Advance Cannabis Research</A></FONT></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><u></u></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 43%">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canopy Growth Corporation</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Bruce Linton</p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Linton</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Date: November 27, 2018 </p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">2</p>




<p style="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED NOVEMBER 27, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>



<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT="Logo: Canopy Growth Corporation (CNW Group|Canopy Growth Corporation)" STYLE="height: 144px; width: 144px"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Battelle and Canopy Growth Announce Strategic
Collaboration to Advance Cannabis Research</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Cannabis leader has completed four federally
legal shipments of cannabis to the United States to pursue advanced R&amp;D work with Battelle</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">COLUMBUS, OH&nbsp;and SMITHS FALLS, ON, Nov.
27, 2018 /CNW/ -&nbsp;Battelle, the world's largest nonprofit research and development organization, and Canopy Growth Corporation
(&quot;Canopy Growth&quot;) (TSX: WEED) (NYSE: CGC), the world's largest diversified cannabis company, today announced the completion
of multiple fully legal cannabis imports from Canada to the United States. Battelle and Canopy Growth will work together to advance
knowledge surrounding cannabis in support of medical research and novel product development.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth and Battelle completed the rigorous
federal approval process required to import cannabis products into the United States and since October 9th, the organizations have
completed four product transfers to Battelle's secure research facilities pursuant to United States Drug Enforcement Agency approvals.
For decades, Battelle scientists have been developing methods for testing a variety of controlled substances as well as employing
analytical chemistry services for government and private industry.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Notably, product transfers have consisted of
a variety of cannabis form factors, including dried cannabis and Canopy Growth's precisely dosed Softgel capsules.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;As more states, including Ohio, approve
the use of medical cannabis to help individuals with certain illnesses, we believe that Battelle will be able to apply our rigorous
and independent research and analysis to advance knowledge and improve safety in what is essentially uncharted territory,&quot;
said Battelle President and CEO Lou Von Thaer. &quot;We're pleased to work with Canopy Growth, a respected global leader in this
emerging market.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;We're pleased to begin collaborating
with a trusted institution of Battelle's reputation,&quot; said Mark Zekulin, President and Co-CEO of Canopy Growth. &quot;This
offers us a unique ability to advance standardization, intellectual property development and clinical research that can improve
the understanding and legal application of cannabis and cannabinoids around the globe.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">With a DEA Schedule&nbsp;I Researcher License
and product obtained from the National Institute on Drug Abuse drug supply program, that is fully legal at the local, state and
federal level, Battelle is already conducting research and development studies involving human subjects and smoking behavior at
an East Coast research center.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Additional areas of research will now begin
in earnest to build a robust knowledge base surrounding Canopy Growth's suite of cannabis products.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Here's to Future Growth.&nbsp;&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Battelle</B><BR>
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national
laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical
services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the
national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B><BR>
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties
in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a
passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The
Company has operations in 12 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners,
conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary,
Canopy Health Innovations has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through
partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and
building a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New
York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained
in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop
Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few.
Canopy Growth operates ten licensed cannabis production sites with over 4.3 million square feet of production capacity, including
over 500,000 square feet of GMP certified production space. For more information visit www.canopygrowth.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements</B><BR>
This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to collaborative research partnerships. Risks,
uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects
and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company's
ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained
in the Company's annual information form dated June 28, 2017 and filed with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed
on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking
information and forward-looking statements included in this news release are made as of the date of this news release and the Company
does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect
new information, subsequent events or otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_002.jpg" ALT="Logo: Battelle (CNW Group|Canopy Growth Corporation)" STYLE="height: 38px; width: 128px"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Logo: Battelle (CNW Group/Canopy Growth Corporation)</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/November2018/27/c3036.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Contact Battelle: Katy Delaney, 614-424-7208,
delaneyk@battelle.org; T.R. Massey, 614-424-5544, masseytr@battelle.org; Contact Canopy Growth Corporation: Caitlin O'Hara, Media
Relations, Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333
ext. 122; Director: Bruce Linton, tmx@canopygrowth.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 27-NOV-18</P>



<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[0'<4&AO=&]S:&]P(#,N,  X0DE-! 0
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M87-E($,S,#,V' (4 !-796)S:71E1&ES=')I8G5T:6]N' (/  -(14$< @
M @ $_]L 0P $ @,# P($ P,#! 0$! 4)!@4%!04+" @&"0T+#0T-"PP,#A 4
M$0X/$P\,#!(8$A,5%A<7%PX1&1L9%AH4%A<6_]L 0P$$! 0%!04*!@8*%@\,
M#Q86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86_\  $0@ D "0 P$B  (1 0,1 ?_$ !P  0 " P$! 0
M   &!P0%" ," ?_$ #<0  $# P0! P,"! ,)      $" P0 !1$&!Q(A,1-!
M40@4(C)A%2-Q@3-"D0D6&"0E4F*2H?_$ !H! 0 " P$                !
M @,$!0;_Q  O$0 " 0,!!08%!0           0(#!!$A!1(3,9$405%24^$&
M%18B<3)A@:'1_]H # ,!  (1 Q$ /P#OZE*4 I2E *4I0"E*4 I2E *4I0"E
M*4 I2E *4I0"E*4 I2E *4I0"E*4 I7P\ZAH!3B@E)( ).!DG %?23D9J,@_
M:4I4@4I2@%*4H!2E* 4I2@%*4H!2E#T* QKA.AP@DRY;#'+/'U7 GECSC/FJ
MMWXW-AVO3\VSVB8Y'O)66E!06RXT@9RXVK&#^Q\>?BHI]3^N+8_J&+;(I1+%
MN]1$ELMCIP]<23@E.,'(.,IJFKO>Y5U4M5P_FGT@AKB>(;((PKCX^<@8R3DY
M->5VKMO<<Z-+GRR=6TL=[=J2Z&YDZAO-UM\:-$G3'1%BI:6PM2E9PK.1G\?)
M'^E2W2F[^K-+F-!O 4]&::!3'D-@N*3UQ 4.T# ZY9^:@]LFN0X4R) 8>>3)
M*?79=:("6F\.*_)*B1DYS\8!R#6+=7W+U(3]K#CL)88+BTL](]B3DC)(& <D
M^.J\]3NZ]+[X3>\=%T:<_ME%8.F;+OEHRX04/!<MA]2L*C.,_FGQDY!(P,CN
MK!L%U@7FSQ[G;9*)$24CU&74@@+3\]]UPHPV[ZR5-)"^*@!D<@I6?&/<'%6C
MLYNQ/TZE%NDK#\8J4H1U%* 3PP/YA\%2NP ,>WN,=W9_Q#*4]VX6GBC0N-FJ
M*S2.IZ5%MN];6W5,)M32'(TM0)5&<[( QE25#I2>P,]?TJ4YKU5.K"I'>B\H
MY,HN+PQ2E*R$"E*4 I2M=JF_V;3=I5<[[<HUOB)6EOU9#@0"M1PE(S^I1/02
M,DGP* V-,C.*T.CM::7U6[-9T]>HMP>MRTHG,-*P[$6K/%+J#A2%$))PH X[
M\5I;JQM7?+))UO/AZ=N4%'J"3=5LMO('HK+2^2\']"D%)^.)^* G!\5H==:G
MBZ:MZ9+[2Y"R2?0:.72D DJ"?<#'_P!_M4*N#FP,'1L+5LIG1;=AN2@B'<_1
M9,:0HD@!#@!!)(( ]SUYZIJR%L)89B&K]9M(1Y C"24O6YM2V6"?\5>$DMMY
MS^:L)Z/?1JE12<6HO#)CC.I5FJ+EI77#[M^M>GY N[P*W(2UH])'!'):\#CR
M&/U9('?+L]5&[O9-.0K(B>RM]:)D=M3:W4N.-QSQ'/\ FI 2XK]70 "3CL@'
M-ZZDMWT_:?-N5>K+H>#_ !I(-N4[ 8Q.!&0&B$D.9'8 SD=^*^)-P^G:';;9
MZK6@4Q+J^N/;1]K&4B2\D@+:; 2<N D H_4#Y%<&IL+BMRG)9??N^YOPOMS2
M*>/R<\3KE]G:_M(EP::)=3A4=8RH!'ZU$9)*@OYZ_)..J\M,V6?*ND)##4O,
ME*E-&*T7%XX*P4@$9_?OP>_<5U#:;'LI<]67#3$#36C)%XM24KGP6[5'+T5*
MOTE:>'X@YZ/O[5@ZID[!:5F2HM[@Z+MR[>D&9SM[(3"2H9'K*2CBUR'CF4YS
M[YK7^FDY)RJ?U[F7YGA-*.ISI:H$>';#>F;C;B8N0J+(6.3^%=+0G.<?'OE/
MOW7U:C=;_<$0[=#CH>E/!Y@)"6W9"T) Z</6  3Y"059^*Z$OJ?IXL]X1:;M
M9]!1)QC"4B*_:XX<+! /J!/#]'Y#*O SWBMI=+%LE#TFQJ29I_0Z;.ZE!C33
M BJ8="R @-J"2%%1P$A.23@#-2OAN.BXFGX]R/F3Y[NI0]GG7?;S4K5SM]RB
M2I('I2@S*#S*D @J2LCP.60%'&>\>]=2Z2NS=VL$6X$MI+[?(\5?CGY3GLCX
M/N.ZKYS_ (>&M,3K](M&@X]LMKR6;@^_:X[:8;A\)>2I +1P0?S Z.:]X*]A
M'[Y;+'%MVB57"\Q1+ML-%O8]66P<D.-IX94CH_D.JZUA82M&TIYB^[P-2O75
M;#:U+,+K0\N(_P#85])(4 4D$'P15/KU/]-*4$J?V^ "WD*S%CY"F0"\"./7
MI@@K_P"W(SBI+;]UMIX6FY$F'K'3\:U69#")"FI"4,PD.))9Y8P$(4E)*2<
M@=5TC6)Y2HK,W)T+$G6F%*U1;F9-^0'+6RMW"YJ3X+2<97_;P.SU4J!R* 51
MGU#SX]A^I7:S4>JGD1M(Q$W2/][(/&+"NCK3:8RWE'\4%3?KH0I704HC(S5Y
MUXSH<6;$<BS(S4AAY/%UIU 6A8^"D]$?UH"I=QM;:/@1KZ[HRY6H:IU"J'98
M]Q3(2EI^8YZB&$%X9"ELH4XZH)!4E''/E(,+V+NEMVRUMN1M%=YMGL\=B/\
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MV@C\5=G/6<YK*4*'UC<)+/U(;(.WO55CG-/*NRXYBQ_M^EVWBDY+S@6%'H8
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0 I2E *4I0"E*4 I2E ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  F ( # 2(  A$! Q$!_\0
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-]>,9Z&BBFF[BMH?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
